Clinical Trial Update: Prevention of GBS Colonization Via Immunity [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on an investigational vaccine aimed at preventing Group B Streptococcal colonization, with results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Group Streptococcal Infection

Drugs mentioned

• GBS vaccine (investigational) (Group B Streptococcus vaccine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Beta Haemolytic Streptococcal Infection | Phase 2 | Status: COMPLETED | Results posted: 2010-07-05